Study of Aripiprazole in Patients With a History of Bipolar Disorder

Completed · Phase 3

Conditions studied: Bipolar Disorder

In brief

The purpose of this study is to learn if aripiprazole is effective in the treatment of patients with a history of bipolar disorder.

Key facts

Study ID

NCT00036348

Run by

Otsuka Pharmaceutical Development & Commercialization, Inc.

Starts

2000-03-01

Expected to finish

2003-06-01

Last updated by the study team

2013-11-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Local Institution — Birmingham, Alabama, United States
• Local Institution — Tuscaloosa, Alabama, United States
• Local Institution — Chillicothe, California, United States
• Local Institution — Riverside, California, United States
• Local Institution — Stanford, California, United States
• Local Institution — Torrance, California, United States
• Local Institution — Atlanta, Georgia, United States
• Local Institution — Chicago, Illinois, United States
• Local Institution — Louisville, Kentucky, United States
• Local Institution — Shreveport, Louisiana, United States
• Local Institution — Belmont, Massachusetts, United States
• Local Institution — Las Vegas, Nevada, United States
• Local Institution — Albuquerque, New Mexico, United States
• Local Institution — New York, New York, United States
• Local Institution — Philadelphia, Pennsylvania, United States
• Local Institution — Memphis, Tennessee, United States
• Local Institution — Nashville, Tennessee, United States
• Local Institution — Austin, Texas, United States
• Local Institution — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.